Cover Image
市場調查報告書

流感診斷市場:檢驗類別(迅速流感診斷檢驗(RIDT),逆轉錄聚合酵素鏈鎖反應(RT-OCR),細胞培養,其他 - 免疫螢光檢驗,血清學),各最終用途,及市場區隔預測

Influenza Diagnostics Market By Test Type (Rapid Influenza Diagnostic Test [RIDT], Reverse Transcription Polymerase Chain Reaction[RT-PCR], Cell Culture, Others - Immunofluorescence, Serology), By End Use, And Segment Forecasts To 2024

出版商 Grand View Research, Inc. 商品編碼 374606
出版日期 內容資訊 英文 77 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
流感診斷市場:檢驗類別(迅速流感診斷檢驗(RIDT),逆轉錄聚合酵素鏈鎖反應(RT-OCR),細胞培養,其他 - 免疫螢光檢驗,血清學),各最終用途,及市場區隔預測 Influenza Diagnostics Market By Test Type (Rapid Influenza Diagnostic Test [RIDT], Reverse Transcription Polymerase Chain Reaction[RT-PCR], Cell Culture, Others - Immunofluorescence, Serology), By End Use, And Segment Forecasts To 2024
出版日期: 2016年09月29日 內容資訊: 英文 77 Pages
簡介

本報告提供全球流感診斷市場相關調查,市場概要和今後預測,彙整各市場區隔及地區別趨勢,及加入此市場的主要企業簡介等資料。

第1章 調查方法與範圍

第2章 摘要整理

第3章 市場概要

第4章 市場變動,趨勢,範圍

  • 市場區隔和範圍
    • 推動市場的要素分析
    • 阻礙市場的要素分析
  • 優先的機會
  • SWOT
  • 產業分析:波特五力分析
  • 市場佔有率分析

第5章 市場類別1:各類型預測與趨勢分析

  • 流感診斷市場:各技術趨勢分析
  • RIDT
  • RT-PCR
  • 細胞培養
  • 其他

第6章 市場類別2:各最終用途預測與趨勢分析

  • 流感診斷市場:各最終用途趨勢分析
  • 醫院
  • POCT
  • 實驗室

第7章 市場類別3:各地區預測及趨勢分析

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 競爭環境

  • 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GVR-1-68038-259-4

The influenza diagnostics market is expected to reach USD 3.3 billion by 2024, according to a new report by Grand View Research, Inc. Influenza, or "the flu," is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on public health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC's seasonal influenza vaccination for prevention and control of seasonal influenza; and the demand created for influenza diagnosis in the flu season.

Rapid Influenza Diagnostic Tests (RIDTs) accounted for the largest share in 2015. RIDTs are tests that deliver accurate results in approximately 15 minutes. This factor deems them efficient, which has resulted in the lucrative growth of this segment with the fastest CAGR. Reverse transcription polymerase chain reaction (RT-PCR) holds the second highest market share following RIDTs, and this can be attributed to the fact that it provides detailed analytical results, sharper turnaround times, and high throughput.

Hospitals held the highest market share in 2015, but Point-of-Care Testing (POCT) is anticipated to overtake and lead the market in the coming future, owing to the increasing usage of POCT because of its ease of use and short turnaround times.

North America dominates the market, due to a high focus of the government and healthcare bodies to control influenza.

Further Key Findings From the Study Suggest:

North America is anticipated to dominate the global influenza diagnostics market. The high adoption rates of in vitro diagnostics and presence of technologically advanced medical devices is expected to drive growth in the region.

The Asia Pacific region is anticipated to be the fastest growing region in the study period. This growth is attributed to factors such as increasing initiatives by the countries to counter the incidence of the disease. For instance, CDC reached a cooperative agreement with South-East Asian Region to fund non research-related bilateral influenza as a measure to respond to avian, seasonal, and pandemic influenza.

The RIDT segment is expected to grow at a significant rate compared to others and accounts for the largest share in 2015.

This market comprises several local as well as global players. Some of the major players of this vertical include Becton, Dickinson and Company, Roche Diagnostics, Alere, Quidel Corporation, and Thermo Fisher Scientific.

Table of Content

Chapter 1 Research Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Market Snapshot

Chapter 4 Market Variables, Trends& Scope

  • 4.1 Market Segmentation&Scope
    • 4.1.1 Market driver analysis
      • 4.1.1.1 Rising base of geriatric population (aged 65 years or older)
      • 4.1.1.2 Increasing prevalence of chronic diseases such as respiratory, heart and blood disorders
      • 4.1.1.3 Growing government initiatives to counter influenza
      • 4.1.1.4 Emergence of technologically advanced influenza diagnostics tests
    • 4.1.2 Market restraint analysis
      • 4.1.2.1 Product safety and high cost of development
  • 4.2 Key Opportunities Prioritized
  • 4.3 Influenza Diagnostics Market- SWOT Analysis, by Factor (Political & Legal, Economic & Technological)
  • 4.4 Industry Analysis - Porter's Five Forces Analysis
  • 4.5 Influenza Diagnostics Market: Market Share Analysis, 2015

Chapter 5 Market Categorization 1: Test Type Estimates & Trend Analysis

  • 5.1 Influenza Diagnostics Market: Technology Movement Analysis
  • 5.2 RIDT
    • 5.2.1 Market estimates and forecasts, 2013 - 2024 (USD Million)
  • 5.3 RT-PCR
    • 5.3.1 Market estimates and forecasts, 2013 - 2024 (USD Million)
  • 5.4 Cell Culture
    • 5.4.1 Market estimates and forecasts, 2013 - 2024 (USD Million)
  • 5.5 Others
    • 5.5.1 Market estimates and forecasts, 2013 - 2024 (USD Million)

Chapter 6 Market Categorization 2: End-use Estimates & Trend Analysis

  • 6.1 Influenza Diagnostics Devices Market: Technology Movement Analysis
  • 6.2 Hospitals
    • 6.2.1 Market estimates and forecasts, 2013 - 2024 (USD Million)
  • 6.3 POCT
    • 6.3.1 Market estimates and forecasts, 2013 - 2024 (USD Million)
  • 6.4 Laboratories
    • 6.4.1 Market estimates and forecasts, 2013 - 2024 (USD Million)

Chapter 7 Market Categorization 3: Regional Estimates & Trend Analysis, by Application and Technology

  • 7.1 Influenza Diagnostics Devices Market Share by Region, 2015 & 2024
  • 7.2 North America
    • 7.2.1 North America influenza diagnostics market, 2013 - 2024 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. influenza diagnostics market, 2013 - 2024 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada influenza diagnostics market, 2013 - 2024 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe influenza diagnostics market, 2013 - 2024 (USD Million)
    • 7.3.2 UK
      • 7.3.2.1 UK influenza diagnostics market, 2013 - 2024 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Germany influenza diagnostics market, 2013 - 2024 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific influenza diagnostics market, 2013 - 2024 (USD Million)
    • 7.4.2 China
      • 7.4.2.1 China influenza diagnostics market, 2013 - 2024 (USD Million)
    • 7.4.3 India
      • 7.4.3.1 India influenza diagnostics market, 2013 - 2024 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America influenza diagnostics market, 2013 - 2024 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil influenza diagnostics market, 2013 - 2024 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico influenza diagnostics market, 2013 - 2024 (USD Million)
  • 7.6 MEA
    • 7.6.1 MEA influenza diagnostics market, 2013 - 2024 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa influenza diagnostics market, 2013 - 2024 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia influenza diagnostics market, 2013 - 2024 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Company Profiles
    • 8.1.1 Becton, Dickinson and Company
      • 8.1.1.1 Company overview
      • 8.1.1.2 Financial performance
      • 8.1.1.3 Product benchmarking
      • 8.1.1.4 Strategic initiatives
    • 8.1.2 Quidel Corporation
      • 8.1.2.1 Company overview
      • 8.1.2.2 Financial performance
      • 8.1.2.3 Product benchmarking
      • 8.1.2.4 Strategic initiatives
    • 8.1.3 Roche
      • 8.1.3.1 Company overview
      • 8.1.3.2 Financial performance
      • 8.1.3.3 Product benchmarking
      • 8.1.3.4 Strategic initiatives
    • 8.1.4 Sekisui Diagnostics, LLC
      • 8.1.4.1 Company overview
      • 8.1.4.2 Financial performance
      • 8.1.4.3 Product benchmarking
      • 8.1.4.4 Strategic initiatives
    • 8.1.5 SA Scientific Ltd.
      • 8.1.5.1 Company overview
      • 8.1.5.2 Financial performance
      • 8.1.5.3 Product benchmarking
      • 8.1.5.4 Strategic initiatives
    • 8.1.6 Meridian Bioscience, Inc.
      • 8.1.6.1 Company overview
      • 8.1.6.2 Financial performance
      • 8.1.6.3 Product benchmarking
    • 8.1.7 Thermo Fisher Scientific
      • 8.1.7.1 Company overview
      • 8.1.7.2 Financial performance
      • 8.1.7.3 Product benchmarking
    • 8.1.8 3M Health Care
      • 8.1.8.1 Company overview
      • 8.1.8.2 Financial performance
      • 8.1.8.3 Product benchmarking
      • 8.1.8.4 Strategic initiatives
    • 8.1.9 Alere
      • 8.1.9.1 Company overview
      • 8.1.9.2 Financial performance
      • 8.1.9.3 Product benchmarking
      • 8.1.9.4 Strategic initiatives

List of Tables

TABLE 1 North America influenza diagnostics market, 2013 - 2024 (USD Million)

TABLE 2 North America influenza diagnostics market, by test type, 2013 - 2024 (USD Million)

TABLE 3 North America influenza diagnostics market, by end use, 2013 - 2024 (USD Million)

TABLE 4 U.S. influenza diagnostics market, by test type, 2013 - 2024 (USD Million)

TABLE 5 U.S. influenza diagnostics market, by end use, 2013 - 2024 (USD Million)

TABLE 6 Canada influenza diagnostics market, by test type, 2013 - 2024 (USD Million)

TABLE 7 Canada influenza diagnostics market, by end use, 2013 - 2024 (USD Million)

TABLE 8 Europeinfluenza diagnostics market, 2013 - 2024 (USD Million)

TABLE 9 Europeinfluenza diagnostics market, by test type, 2013 - 2024 (USD Million))

TABLE 10 Europeinfluenza diagnostics market, by end use, 2013 - 2024 (USD Million)

TABLE 11 UK influenza diagnostics market, by test type, 2013 - 2024 (USD Million)

TABLE 12 UK influenza diagnostics market, by end use, 2013 - 2024 (USD Million)

TABLE 13 Germanyinfluenza diagnostics market, by test type, 2013 - 2024 (USD Million)

TABLE 14 Germanyinfluenza diagnostics market, by end use, 2013 - 2024 (USD Million)

TABLE 15 Asia Pacificinfluenza diagnostics market, 2013 - 2024 (USD Million)

TABLE 16 Asia Pacificinfluenza diagnostics market, by test type, 2013 - 2024 (USD Million))

TABLE 17 Asia Pacificinfluenza diagnostics market, by enduse, 2013 - 2024 (USD Million)

TABLE 18 Chinainfluenza diagnostics market, by test type, 2013 - 2024 (USD Million)

TABLE 19 Chinainfluenza diagnostics market, by enduse, 2013 - 2024 (USD Million)

TABLE 20 Indiainfluenza diagnostics market, by test type, 2013 - 2024 (USD Million)

TABLE 21 Indiainfluenza diagnostics market, byenduse, 2013 - 2024 (USD Million)

TABLE 22 Latin America influenza diagnostics market, 2013 - 2024 (USD Million)

TABLE 23 Latin America influenza diagnostics market, by test type, 2013 - 2024 (USD Million))

TABLE 24 Latin Americainfluenza diagnostics market, by end use, 2013 - 2024 (USD Million)

TABLE 25 Brazil influenza diagnostics market, by test type, 2013 - 2024 (USD Million)

TABLE 26 Brazil influenza diagnostics market, by enduse, 2013 - 2024 (USD Million)

TABLE 27 Mexicoinfluenza diagnostics market, by test type, 2013 - 2024 (USD Million)

TABLE 28 Mexicoinfluenza diagnostics market, by enduse, 2013 - 2024 (USD Million)

TABLE 29 MEAinfluenza diagnostics market, 2013 - 2024 (USD Million)

TABLE 30 MEA influenza diagnostics market, by test type 2013 - 2024 (USD Million)

TABLE 31 MEAinfluenza diagnostics market, by enduse 2013 - 2024 (USD Million)

TABLE 32 South Africa influenza diagnostics market, by test type, 2013 - 2024 (USD Million)

TABLE 33 South Africa influenza diagnostics market, by end use, 2013 - 2024 (USD Million)

TABLE 34 Saudi Arabia influenza diagnostics market, by test type, 2013 - 2024 (USD Million)

TABLE 33 Saudi Arabia influenza diagnostics market, by end use, 2013 - 2024 (USD Million)

List of Figures

  • FIG.1 Market research process
  • FIG.2 Information procurement
  • FIG.3 Primary research pattern
  • FIG.4 Market research approaches
  • FIG.5 QFD modeling for market share assessment
  • FIG.6 Market summary
  • FIG.7 Market trends & outlook
  • FIG.8 Influenza diagnostics: Market segmentation& scope
  • FIG.9 Influenza diagnostics market driver relevance analysis (Current & future impact)
  • FIG.10 Key opportunities prioritized
  • FIG.11 SWOT Analysis, by Factor (Political & legal, economic and technological)
  • FIG.12 Influenza diagnostics market: Porter's Five Forces Analysis
  • FIG.13 Influenza diagnostics market: Company market share analysis, 2015
  • FIG.14 Influenza diagnostics market test type outlook: Key takeaways
  • FIG.15 RIDT influenza diagnostics market, 2013 - 2024 (USD Million)
  • FIG.16 RT-PCR influenza diagnostics market, 2013 - 2024 (USD Million)
  • FIG.17 Cell culture influenza diagnostics market, 2013 - 2024 (USD Million)
  • FIG.18 Other Influenza diagnostics market, 2013 - 2024 (USD Million)
  • FIG.19 Influenza diagnostics market end use outlook: Key takeaways
  • FIG.20 Hospitalmarket, 2013 - 2024 (USD Million)
  • FIG.21 POCTmarket, 2013 - 2024 (USD Million)
  • FIG.22 Laboratories market, 2013 - 2024 (USD Million)
  • FIG.23 Regional market place: Key takeaways
  • FIG.24 Regional outlook, 2016 & 2024
Back to Top